|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:LARP4B-PAMR1 (FusionGDB2 ID:43913) |
Fusion Gene Summary for LARP4B-PAMR1 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: LARP4B-PAMR1 | Fusion gene ID: 43913 | Hgene | Tgene | Gene symbol | LARP4B | PAMR1 | Gene ID | 23185 | 25891 |
| Gene name | La ribonucleoprotein 4B | peptidase domain containing associated with muscle regeneration 1 | |
| Synonyms | KIAA0217|LARP5 | DKFZP586H2123|FP938|RAMP | |
| Cytomap | 10p15.3 | 11p13 | |
| Type of gene | protein-coding | protein-coding | |
| Description | la-related protein 4BLa ribonucleoprotein domain family member 4BLa ribonucleoprotein domain family, member 5la-related protein 5 | inactive serine protease PAMR1peptidase domain-containing protein associated with muscle regeneration 1regeneration associated muscle proteaseregeneration-associated muscle protease homolog | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | Q92615 | . | |
| Ensembl transtripts involved in fusion gene | ENST00000316157, ENST00000469487, | ENST00000278360, ENST00000378880, ENST00000378878, ENST00000532848, ENST00000534803, | |
| Fusion gene scores | * DoF score | 13 X 11 X 8=1144 | 5 X 4 X 4=80 |
| # samples | 14 | 5 | |
| ** MAII score | log2(14/1144*10)=-3.03058831983342 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/80*10)=-0.678071905112638 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: LARP4B [Title/Abstract] AND PAMR1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | LARP4B(909683)-PAMR1(35515820), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Fusion gene breakpoints across LARP4B (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene breakpoints across PAMR1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | SKCM | TCGA-FS-A4F4-06A | LARP4B | chr10 | 909683 | - | PAMR1 | chr11 | 35515820 | - |
Top |
Fusion Gene ORF analysis for LARP4B-PAMR1 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| In-frame | ENST00000316157 | ENST00000278360 | LARP4B | chr10 | 909683 | - | PAMR1 | chr11 | 35515820 | - |
| In-frame | ENST00000316157 | ENST00000378880 | LARP4B | chr10 | 909683 | - | PAMR1 | chr11 | 35515820 | - |
| In-frame | ENST00000316157 | ENST00000378878 | LARP4B | chr10 | 909683 | - | PAMR1 | chr11 | 35515820 | - |
| 5CDS-5UTR | ENST00000316157 | ENST00000532848 | LARP4B | chr10 | 909683 | - | PAMR1 | chr11 | 35515820 | - |
| 5CDS-5UTR | ENST00000316157 | ENST00000534803 | LARP4B | chr10 | 909683 | - | PAMR1 | chr11 | 35515820 | - |
| intron-3CDS | ENST00000469487 | ENST00000278360 | LARP4B | chr10 | 909683 | - | PAMR1 | chr11 | 35515820 | - |
| intron-3CDS | ENST00000469487 | ENST00000378880 | LARP4B | chr10 | 909683 | - | PAMR1 | chr11 | 35515820 | - |
| intron-3CDS | ENST00000469487 | ENST00000378878 | LARP4B | chr10 | 909683 | - | PAMR1 | chr11 | 35515820 | - |
| intron-5UTR | ENST00000469487 | ENST00000532848 | LARP4B | chr10 | 909683 | - | PAMR1 | chr11 | 35515820 | - |
| intron-5UTR | ENST00000469487 | ENST00000534803 | LARP4B | chr10 | 909683 | - | PAMR1 | chr11 | 35515820 | - |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000316157 | LARP4B | chr10 | 909683 | - | ENST00000278360 | PAMR1 | chr11 | 35515820 | - | 3146 | 471 | 41 | 2611 | 856 |
| ENST00000316157 | LARP4B | chr10 | 909683 | - | ENST00000378880 | PAMR1 | chr11 | 35515820 | - | 3095 | 471 | 41 | 2560 | 839 |
| ENST00000316157 | LARP4B | chr10 | 909683 | - | ENST00000378878 | PAMR1 | chr11 | 35515820 | - | 2754 | 471 | 41 | 2227 | 728 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000316157 | ENST00000278360 | LARP4B | chr10 | 909683 | - | PAMR1 | chr11 | 35515820 | - | 0.004074353 | 0.99592566 |
| ENST00000316157 | ENST00000378880 | LARP4B | chr10 | 909683 | - | PAMR1 | chr11 | 35515820 | - | 0.004455267 | 0.99554473 |
| ENST00000316157 | ENST00000378878 | LARP4B | chr10 | 909683 | - | PAMR1 | chr11 | 35515820 | - | 0.007736863 | 0.9922631 |
Top |
Fusion Genomic Features for LARP4B-PAMR1 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for LARP4B-PAMR1 |
| Go to FGviewer for the breakpoints of chr10:909683-chr11:35515820 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| LARP4B | . |
| FUNCTION: Stimulates mRNA translation. {ECO:0000269|PubMed:20573744}. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | PAMR1 | chr10:909683 | chr11:35515820 | ENST00000278360 | 0 | 12 | 42_94 | 24.333333333333332 | 738.0 | Compositional bias | Note=Cys-rich | |
| Tgene | PAMR1 | chr10:909683 | chr11:35515820 | ENST00000378880 | 0 | 11 | 42_94 | 24.333333333333332 | 721.0 | Compositional bias | Note=Cys-rich | |
| Tgene | PAMR1 | chr10:909683 | chr11:35515820 | ENST00000278360 | 0 | 12 | 128_236 | 24.333333333333332 | 738.0 | Domain | CUB | |
| Tgene | PAMR1 | chr10:909683 | chr11:35515820 | ENST00000278360 | 0 | 12 | 235_272 | 24.333333333333332 | 738.0 | Domain | EGF-like | |
| Tgene | PAMR1 | chr10:909683 | chr11:35515820 | ENST00000278360 | 0 | 12 | 278_344 | 24.333333333333332 | 738.0 | Domain | Sushi 1 | |
| Tgene | PAMR1 | chr10:909683 | chr11:35515820 | ENST00000278360 | 0 | 12 | 387_444 | 24.333333333333332 | 738.0 | Domain | Sushi 2 | |
| Tgene | PAMR1 | chr10:909683 | chr11:35515820 | ENST00000278360 | 0 | 12 | 445_720 | 24.333333333333332 | 738.0 | Domain | Peptidase S1 | |
| Tgene | PAMR1 | chr10:909683 | chr11:35515820 | ENST00000378880 | 0 | 11 | 128_236 | 24.333333333333332 | 721.0 | Domain | CUB | |
| Tgene | PAMR1 | chr10:909683 | chr11:35515820 | ENST00000378880 | 0 | 11 | 235_272 | 24.333333333333332 | 721.0 | Domain | EGF-like | |
| Tgene | PAMR1 | chr10:909683 | chr11:35515820 | ENST00000378880 | 0 | 11 | 278_344 | 24.333333333333332 | 721.0 | Domain | Sushi 1 | |
| Tgene | PAMR1 | chr10:909683 | chr11:35515820 | ENST00000378880 | 0 | 11 | 387_444 | 24.333333333333332 | 721.0 | Domain | Sushi 2 | |
| Tgene | PAMR1 | chr10:909683 | chr11:35515820 | ENST00000378880 | 0 | 11 | 445_720 | 24.333333333333332 | 721.0 | Domain | Peptidase S1 |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | LARP4B | chr10:909683 | chr11:35515820 | ENST00000316157 | - | 4 | 17 | 150_239 | 143.33333333333334 | 739.0 | Domain | HTH La-type RNA-binding |
| Hgene | LARP4B | chr10:909683 | chr11:35515820 | ENST00000316157 | - | 4 | 17 | 240_307 | 143.33333333333334 | 739.0 | Domain | Note=RRM |
Top |
Fusion Gene Sequence for LARP4B-PAMR1 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >In-frame_ENST00000316157_ENST00000278360_TCGA-FS-A4F4-06A_LARP4B_chr10_909683_-_PAMR1_chr11_35515820_length(transcript)=3146nt_BP=471nt AGCATCCTGAGGTTAGCATTACACTTCTCCCAGTGGAGCCCATGACTTCTGATCAGGACGCTAAGGTTGTGGCTGAACCGCAGACGCAGA GAGTCCAGGAGGGCAAGGACAGCGCTCATCTGATGAATGGTCCTATATCTCAAACCACTTCTCAGACAAGTTCCATCCCACCTTTGAGTC AGGTACCAGCAACTAAGGTTTCAGAGCTGAACCCTAATGCAGAAGTGTGGGGGGCTCCTGTGTTACATCTGGAAGCAAGCAGTGCTGCTG ACGGTGTGAGTGCTGCATGGGAGGAGGTGGCTGGCCACCACGCAGACCGTGGCCCGCAGGGATCGGATGCCAATGGTGATGGTGACCAGG GCCATGAGAATGCCGCATTGCCAGACCCGCAGGAGTCGGACCCAGCAGACATGAACGCTCTCGCTCTGGGTCCCTCAGAATATGACTCTC TGCCTGAAAATAGCGAGACAGAGTACACAGTCATTAATGAAGCCTGCCCTGGAGCAGAGTGGAATATCATGTGTCGGGAGTGCTGTGAAT ATGATCAGATTGAGTGCGTCTGCCCCGGAAAGAGGGAAGTCGTGGGTTATACCATCCCTTGCTGCAGGAATGAGGAGAATGAGTGTGACT CCTGCCTGATCCACCCAGGTTGTACCATCTTTGAAAACTGCAAGAGCTGCCGAAATGGCTCATGGGGGGGTACCTTGGATGACTTCTATG TGAAGGGGTTCTACTGTGCAGAGTGCCGAGCAGGCTGGTACGGAGGAGACTGCATGCGATGTGGCCAGGTTCTGCGAGCCCCAAAGGGTC AGATTTTGTTGGAAAGCTATCCCCTAAATGCTCACTGTGAATGGACCATTCATGCTAAACCTGGGTTTGTCATCCAACTAAGATTTGTCA TGTTGAGCCTGGAGTTTGACTACATGTGCCAGTATGACTATGTTGAGGTTCGTGATGGAGACAACCGCGATGGCCAGATCATCAAGCGTG TCTGTGGCAACGAGCGGCCAGCTCCTATCCAGAGCATAGGATCCTCACTCCACGTCCTCTTCCACTCCGATGGCTCCAAGAATTTTGACG GTTTCCATGCCATTTATGAGGAGATCACAGCATGCTCCTCATCCCCTTGTTTCCATGACGGCACGTGCGTCCTTGACAAGGCTGGATCTT ACAAGTGTGCCTGCTTGGCAGGCTATACTGGGCAGCGCTGTGAAAATCTTCTGGAGGCTGGGAAGTCCAAGATCAAGGCGTCAGAAGATT CATTGTCTGTCCTTGAAGAAAGAAACTGCTCAGACCCTGGGGGCCCAGTCAATGGGTACCAGAAAATAACAGGGGGCCCTGGGCTTATCA ACGGACGCCATGCTAAAATTGGCACCGTGGTGTCTTTCTTTTGTAACAACTCCTATGTTCTTAGTGGCAATGAGAAAAGAACTTGCCAGC AGAATGGAGAGTGGTCAGGGAAACAGCCCATCTGCATAAAAGCCTGCCGAGAACCAAAGATTTCAGACCTGGTGAGAAGGAGAGTTCTTC CGATGCAGGTTCAGTCAAGGGAGACACCATTACACCAGCTATACTCAGCGGCCTTCAGCAAGCAGAAACTGCAGAGTGCCCCTACCAAGA AGCCAGCCCTTCCCTTTGGAGATCTGCCCATGGGATACCAACATCTGCATACCCAGCTCCAGTATGAGTGCATCTCACCCTTCTACCGCC GCCTGGGCAGCAGCAGGAGGACATGTCTGAGGACTGGGAAGTGGAGTGGGCGGGCACCATCCTGCATCCCTATCTGCGGGAAAATTGAGA ACATCACTGCTCCAAAGACCCAAGGGTTGCGCTGGCCGTGGCAGGCAGCCATCTACAGGAGGACCAGCGGGGTGCATGACGGCAGCCTAC ACAAGGGAGCGTGGTTCCTAGTCTGCAGCGGTGCCCTGGTGAATGAGCGCACTGTGGTGGTGGCTGCCCACTGTGTTACTGACCTGGGGA AGGTCACCATGATCAAGACAGCAGACCTGAAAGTTGTTTTGGGGAAATTCTACCGGGATGATGACCGGGATGAGAAGACCATCCAGAGCC TACAGATTTCTGCTATCATTCTGCATCCCAACTATGACCCCATCCTGCTTGATGCTGACATCGCCATCCTGAAGCTCCTAGACAAGGCCC GTATCAGCACCCGAGTCCAGCCCATCTGCCTCGCTGCCAGTCGGGATCTCAGCACTTCCTTCCAGGAGTCCCACATCACTGTGGCTGGCT GGAATGTCCTGGCAGACGTGAGGAGCCCTGGCTTCAAGAACGACACACTGCGCTCTGGGGTGGTCAGTGTGGTGGACTCGCTGCTGTGTG AGGAGCAGCATGAGGACCATGGCATCCCAGTGAGTGTCACTGATAACATGTTCTGTGCCAGCTGGGAACCCACTGCCCCTTCTGATATCT GCACTGCAGAGACAGGAGGCATCGCGGCTGTGTCCTTCCCGGGACGAGCATCTCCTGAGCCACGCTGGCATCTGATGGGACTGGTCAGCT GGAGCTATGATAAAACATGCAGCCACAGGCTCTCCACTGCCTTCACCAAGGTGCTGCCTTTTAAAGACTGGATTGAAAGAAATATGAAAT GAACCATGCTCATGCACTCCTTGAGAAGTGTTTCTGTATATCCGTCTGTACGTGTGTCATTGCGTGAAGCAGTGTGGGCCTGAAGTGTGA TTTGGCCTGTGAACTTGGGCTGTGCCAGGGCTTCTGACTTCAGGGACAAAACTCAGTGAAGGGTGAGTAGACCTCCATTGCTGGTAGGCT GATGCCGCGTCCACTACTAGGACAGCCAATTGGAAGATGCCAGGGCTTGCAAGAAGTAAGTTTCTTCAAAGAAGACCATATACAAAACCT CTCCACTCCACTGACCTGGTGGTCTTCCCCAACTTTCAGTTATACGAATGCCATCAGCTTGACCAGGGAAGATCTGGGCTTCATGAGGCC CCTTTTGAGGCTCTCAAGTTCTAGAGAGCTGCCTGTGGGACAGCCCAGGGCAGCAGAGCTGGGATGTGGTGCATGCCTTTGTGTACATGG >In-frame_ENST00000316157_ENST00000278360_TCGA-FS-A4F4-06A_LARP4B_chr10_909683_-_PAMR1_chr11_35515820_length(amino acids)=856AA_start in transcript=41_stop in transcript=2611 MTSDQDAKVVAEPQTQRVQEGKDSAHLMNGPISQTTSQTSSIPPLSQVPATKVSELNPNAEVWGAPVLHLEASSAADGVSAAWEEVAGHH ADRGPQGSDANGDGDQGHENAALPDPQESDPADMNALALGPSEYDSLPENSETEYTVINEACPGAEWNIMCRECCEYDQIECVCPGKREV VGYTIPCCRNEENECDSCLIHPGCTIFENCKSCRNGSWGGTLDDFYVKGFYCAECRAGWYGGDCMRCGQVLRAPKGQILLESYPLNAHCE WTIHAKPGFVIQLRFVMLSLEFDYMCQYDYVEVRDGDNRDGQIIKRVCGNERPAPIQSIGSSLHVLFHSDGSKNFDGFHAIYEEITACSS SPCFHDGTCVLDKAGSYKCACLAGYTGQRCENLLEAGKSKIKASEDSLSVLEERNCSDPGGPVNGYQKITGGPGLINGRHAKIGTVVSFF CNNSYVLSGNEKRTCQQNGEWSGKQPICIKACREPKISDLVRRRVLPMQVQSRETPLHQLYSAAFSKQKLQSAPTKKPALPFGDLPMGYQ HLHTQLQYECISPFYRRLGSSRRTCLRTGKWSGRAPSCIPICGKIENITAPKTQGLRWPWQAAIYRRTSGVHDGSLHKGAWFLVCSGALV NERTVVVAAHCVTDLGKVTMIKTADLKVVLGKFYRDDDRDEKTIQSLQISAIILHPNYDPILLDADIAILKLLDKARISTRVQPICLAAS RDLSTSFQESHITVAGWNVLADVRSPGFKNDTLRSGVVSVVDSLLCEEQHEDHGIPVSVTDNMFCASWEPTAPSDICTAETGGIAAVSFP -------------------------------------------------------------- >In-frame_ENST00000316157_ENST00000378880_TCGA-FS-A4F4-06A_LARP4B_chr10_909683_-_PAMR1_chr11_35515820_length(transcript)=3095nt_BP=471nt AGCATCCTGAGGTTAGCATTACACTTCTCCCAGTGGAGCCCATGACTTCTGATCAGGACGCTAAGGTTGTGGCTGAACCGCAGACGCAGA GAGTCCAGGAGGGCAAGGACAGCGCTCATCTGATGAATGGTCCTATATCTCAAACCACTTCTCAGACAAGTTCCATCCCACCTTTGAGTC AGGTACCAGCAACTAAGGTTTCAGAGCTGAACCCTAATGCAGAAGTGTGGGGGGCTCCTGTGTTACATCTGGAAGCAAGCAGTGCTGCTG ACGGTGTGAGTGCTGCATGGGAGGAGGTGGCTGGCCACCACGCAGACCGTGGCCCGCAGGGATCGGATGCCAATGGTGATGGTGACCAGG GCCATGAGAATGCCGCATTGCCAGACCCGCAGGAGTCGGACCCAGCAGACATGAACGCTCTCGCTCTGGGTCCCTCAGAATATGACTCTC TGCCTGAAAATAGCGAGACAGAGTACACAGTCATTAATGAAGCCTGCCCTGGAGCAGAGTGGAATATCATGTGTCGGGAGTGCTGTGAAT ATGATCAGATTGAGTGCGTCTGCCCCGGAAAGAGGGAAGTCGTGGGTTATACCATCCCTTGCTGCAGGAATGAGGAGAATGAGTGTGACT CCTGCCTGATCCACCCAGGTTGTACCATCTTTGAAAACTGCAAGAGCTGCCGAAATGGCTCATGGGGGGGTACCTTGGATGACTTCTATG TGAAGGGGTTCTACTGTGCAGAGTGCCGAGCAGGCTGGTACGGAGGAGACTGCATGCGATGTGGCCAGGTTCTGCGAGCCCCAAAGGGTC AGATTTTGTTGGAAAGCTATCCCCTAAATGCTCACTGTGAATGGACCATTCATGCTAAACCTGGGTTTGTCATCCAACTAAGATTTGTCA TGTTGAGCCTGGAGTTTGACTACATGTGCCAGTATGACTATGTTGAGGTTCGTGATGGAGACAACCGCGATGGCCAGATCATCAAGCGTG TCTGTGGCAACGAGCGGCCAGCTCCTATCCAGAGCATAGGATCCTCACTCCACGTCCTCTTCCACTCCGATGGCTCCAAGAATTTTGACG GTTTCCATGCCATTTATGAGGAGATCACAGCATGCTCCTCATCCCCTTGTTTCCATGACGGCACGTGCGTCCTTGACAAGGCTGGATCTT ACAAGTGTGCCTGCTTGGCAGGCTATACTGGGCAGCGCTGTGAAAATCTCCTTGAAGAAAGAAACTGCTCAGACCCTGGGGGCCCAGTCA ATGGGTACCAGAAAATAACAGGGGGCCCTGGGCTTATCAACGGACGCCATGCTAAAATTGGCACCGTGGTGTCTTTCTTTTGTAACAACT CCTATGTTCTTAGTGGCAATGAGAAAAGAACTTGCCAGCAGAATGGAGAGTGGTCAGGGAAACAGCCCATCTGCATAAAAGCCTGCCGAG AACCAAAGATTTCAGACCTGGTGAGAAGGAGAGTTCTTCCGATGCAGGTTCAGTCAAGGGAGACACCATTACACCAGCTATACTCAGCGG CCTTCAGCAAGCAGAAACTGCAGAGTGCCCCTACCAAGAAGCCAGCCCTTCCCTTTGGAGATCTGCCCATGGGATACCAACATCTGCATA CCCAGCTCCAGTATGAGTGCATCTCACCCTTCTACCGCCGCCTGGGCAGCAGCAGGAGGACATGTCTGAGGACTGGGAAGTGGAGTGGGC GGGCACCATCCTGCATCCCTATCTGCGGGAAAATTGAGAACATCACTGCTCCAAAGACCCAAGGGTTGCGCTGGCCGTGGCAGGCAGCCA TCTACAGGAGGACCAGCGGGGTGCATGACGGCAGCCTACACAAGGGAGCGTGGTTCCTAGTCTGCAGCGGTGCCCTGGTGAATGAGCGCA CTGTGGTGGTGGCTGCCCACTGTGTTACTGACCTGGGGAAGGTCACCATGATCAAGACAGCAGACCTGAAAGTTGTTTTGGGGAAATTCT ACCGGGATGATGACCGGGATGAGAAGACCATCCAGAGCCTACAGATTTCTGCTATCATTCTGCATCCCAACTATGACCCCATCCTGCTTG ATGCTGACATCGCCATCCTGAAGCTCCTAGACAAGGCCCGTATCAGCACCCGAGTCCAGCCCATCTGCCTCGCTGCCAGTCGGGATCTCA GCACTTCCTTCCAGGAGTCCCACATCACTGTGGCTGGCTGGAATGTCCTGGCAGACGTGAGGAGCCCTGGCTTCAAGAACGACACACTGC GCTCTGGGGTGGTCAGTGTGGTGGACTCGCTGCTGTGTGAGGAGCAGCATGAGGACCATGGCATCCCAGTGAGTGTCACTGATAACATGT TCTGTGCCAGCTGGGAACCCACTGCCCCTTCTGATATCTGCACTGCAGAGACAGGAGGCATCGCGGCTGTGTCCTTCCCGGGACGAGCAT CTCCTGAGCCACGCTGGCATCTGATGGGACTGGTCAGCTGGAGCTATGATAAAACATGCAGCCACAGGCTCTCCACTGCCTTCACCAAGG TGCTGCCTTTTAAAGACTGGATTGAAAGAAATATGAAATGAACCATGCTCATGCACTCCTTGAGAAGTGTTTCTGTATATCCGTCTGTAC GTGTGTCATTGCGTGAAGCAGTGTGGGCCTGAAGTGTGATTTGGCCTGTGAACTTGGGCTGTGCCAGGGCTTCTGACTTCAGGGACAAAA CTCAGTGAAGGGTGAGTAGACCTCCATTGCTGGTAGGCTGATGCCGCGTCCACTACTAGGACAGCCAATTGGAAGATGCCAGGGCTTGCA AGAAGTAAGTTTCTTCAAAGAAGACCATATACAAAACCTCTCCACTCCACTGACCTGGTGGTCTTCCCCAACTTTCAGTTATACGAATGC CATCAGCTTGACCAGGGAAGATCTGGGCTTCATGAGGCCCCTTTTGAGGCTCTCAAGTTCTAGAGAGCTGCCTGTGGGACAGCCCAGGGC AGCAGAGCTGGGATGTGGTGCATGCCTTTGTGTACATGGCCACAGTACAGTCTGGTCCTTTTCCTTCCCCATCTCTTGTACACATTTTAA >In-frame_ENST00000316157_ENST00000378880_TCGA-FS-A4F4-06A_LARP4B_chr10_909683_-_PAMR1_chr11_35515820_length(amino acids)=839AA_start in transcript=41_stop in transcript=2560 MTSDQDAKVVAEPQTQRVQEGKDSAHLMNGPISQTTSQTSSIPPLSQVPATKVSELNPNAEVWGAPVLHLEASSAADGVSAAWEEVAGHH ADRGPQGSDANGDGDQGHENAALPDPQESDPADMNALALGPSEYDSLPENSETEYTVINEACPGAEWNIMCRECCEYDQIECVCPGKREV VGYTIPCCRNEENECDSCLIHPGCTIFENCKSCRNGSWGGTLDDFYVKGFYCAECRAGWYGGDCMRCGQVLRAPKGQILLESYPLNAHCE WTIHAKPGFVIQLRFVMLSLEFDYMCQYDYVEVRDGDNRDGQIIKRVCGNERPAPIQSIGSSLHVLFHSDGSKNFDGFHAIYEEITACSS SPCFHDGTCVLDKAGSYKCACLAGYTGQRCENLLEERNCSDPGGPVNGYQKITGGPGLINGRHAKIGTVVSFFCNNSYVLSGNEKRTCQQ NGEWSGKQPICIKACREPKISDLVRRRVLPMQVQSRETPLHQLYSAAFSKQKLQSAPTKKPALPFGDLPMGYQHLHTQLQYECISPFYRR LGSSRRTCLRTGKWSGRAPSCIPICGKIENITAPKTQGLRWPWQAAIYRRTSGVHDGSLHKGAWFLVCSGALVNERTVVVAAHCVTDLGK VTMIKTADLKVVLGKFYRDDDRDEKTIQSLQISAIILHPNYDPILLDADIAILKLLDKARISTRVQPICLAASRDLSTSFQESHITVAGW NVLADVRSPGFKNDTLRSGVVSVVDSLLCEEQHEDHGIPVSVTDNMFCASWEPTAPSDICTAETGGIAAVSFPGRASPEPRWHLMGLVSW -------------------------------------------------------------- >In-frame_ENST00000316157_ENST00000378878_TCGA-FS-A4F4-06A_LARP4B_chr10_909683_-_PAMR1_chr11_35515820_length(transcript)=2754nt_BP=471nt AGCATCCTGAGGTTAGCATTACACTTCTCCCAGTGGAGCCCATGACTTCTGATCAGGACGCTAAGGTTGTGGCTGAACCGCAGACGCAGA GAGTCCAGGAGGGCAAGGACAGCGCTCATCTGATGAATGGTCCTATATCTCAAACCACTTCTCAGACAAGTTCCATCCCACCTTTGAGTC AGGTACCAGCAACTAAGGTTTCAGAGCTGAACCCTAATGCAGAAGTGTGGGGGGCTCCTGTGTTACATCTGGAAGCAAGCAGTGCTGCTG ACGGTGTGAGTGCTGCATGGGAGGAGGTGGCTGGCCACCACGCAGACCGTGGCCCGCAGGGATCGGATGCCAATGGTGATGGTGACCAGG GCCATGAGAATGCCGCATTGCCAGACCCGCAGGAGTCGGACCCAGCAGACATGAACGCTCTCGCTCTGGGTCCCTCAGAATATGACTCTC TGCCTGAAAATAGCGAGACAGAGTACACAGTCATTAATGAAGCCTGCCCTGGAGCAGAGTGGAATATCATGTGTCGGGAGTGCTGTGAAT ATGATCAGATTGAGTGCGTCTGCCCCGGAAAGAGGGAAGTCGTGGGTTATACCATCCCTTGCTGCAGGAATGAGGAGAATGAGTGTGACT CCTGCCTGATCCACCCAGGTTGTACCATCTTTGAAAACTGCAAGAGCTGCCGAAATGGCTCATGGGGGGGTACCTTGGATGACTTCTATG TGAAGGGGTTCTACTGTGCAGAGTGCCGAGCAGGCTGGTACGGAGGAGACTGCATGCCATGCTCCTCATCCCCTTGTTTCCATGACGGCA CGTGCGTCCTTGACAAGGCTGGATCTTACAAGTGTGCCTGCTTGGCAGGCTATACTGGGCAGCGCTGTGAAAATCTCCTTGAAGAAAGAA ACTGCTCAGACCCTGGGGGCCCAGTCAATGGGTACCAGAAAATAACAGGGGGCCCTGGGCTTATCAACGGACGCCATGCTAAAATTGGCA CCGTGGTGTCTTTCTTTTGTAACAACTCCTATGTTCTTAGTGGCAATGAGAAAAGAACTTGCCAGCAGAATGGAGAGTGGTCAGGGAAAC AGCCCATCTGCATAAAAGCCTGCCGAGAACCAAAGATTTCAGACCTGGTGAGAAGGAGAGTTCTTCCGATGCAGGTTCAGTCAAGGGAGA CACCATTACACCAGCTATACTCAGCGGCCTTCAGCAAGCAGAAACTGCAGAGTGCCCCTACCAAGAAGCCAGCCCTTCCCTTTGGAGATC TGCCCATGGGATACCAACATCTGCATACCCAGCTCCAGTATGAGTGCATCTCACCCTTCTACCGCCGCCTGGGCAGCAGCAGGAGGACAT GTCTGAGGACTGGGAAGTGGAGTGGGCGGGCACCATCCTGCATCCCTATCTGCGGGAAAATTGAGAACATCACTGCTCCAAAGACCCAAG GGTTGCGCTGGCCGTGGCAGGCAGCCATCTACAGGAGGACCAGCGGGGTGCATGACGGCAGCCTACACAAGGGAGCGTGGTTCCTAGTCT GCAGCGGTGCCCTGGTGAATGAGCGCACTGTGGTGGTGGCTGCCCACTGTGTTACTGACCTGGGGAAGGTCACCATGATCAAGACAGCAG ACCTGAAAGTTGTTTTGGGGAAATTCTACCGGGATGATGACCGGGATGAGAAGACCATCCAGAGCCTACAGATTTCTGCTATCATTCTGC ATCCCAACTATGACCCCATCCTGCTTGATGCTGACATCGCCATCCTGAAGCTCCTAGACAAGGCCCGTATCAGCACCCGAGTCCAGCCCA TCTGCCTCGCTGCCAGTCGGGATCTCAGCACTTCCTTCCAGGAGTCCCACATCACTGTGGCTGGCTGGAATGTCCTGGCAGACGTGAGGA GCCCTGGCTTCAAGAACGACACACTGCGCTCTGGGGTGGTCAGTGTGGTGGACTCGCTGCTGTGTGAGGAGCAGCATGAGGACCATGGCA TCCCAGTGAGTGTCACTGATAACATGTTCTGTGCCAGCTGGGAACCCACTGCCCCTTCTGATATCTGCACTGCAGAGACAGGAGGCATCG CGGCTGTGTCCTTCCCGGGACGAGCATCTCCTGAGCCACGCTGGCATCTGATGGGACTGGTCAGCTGGAGCTATGATAAAACATGCAGCC ACAGGCTCTCCACTGCCTTCACCAAGGTGCTGCCTTTTAAAGACTGGATTGAAAGAAATATGAAATGAACCATGCTCATGCACTCCTTGA GAAGTGTTTCTGTATATCCGTCTGTACGTGTGTCATTGCGTGAAGCAGTGTGGGCCTGAAGTGTGATTTGGCCTGTGAACTTGGGCTGTG CCAGGGCTTCTGACTTCAGGGACAAAACTCAGTGAAGGGTGAGTAGACCTCCATTGCTGGTAGGCTGATGCCGCGTCCACTACTAGGACA GCCAATTGGAAGATGCCAGGGCTTGCAAGAAGTAAGTTTCTTCAAAGAAGACCATATACAAAACCTCTCCACTCCACTGACCTGGTGGTC TTCCCCAACTTTCAGTTATACGAATGCCATCAGCTTGACCAGGGAAGATCTGGGCTTCATGAGGCCCCTTTTGAGGCTCTCAAGTTCTAG AGAGCTGCCTGTGGGACAGCCCAGGGCAGCAGAGCTGGGATGTGGTGCATGCCTTTGTGTACATGGCCACAGTACAGTCTGGTCCTTTTC >In-frame_ENST00000316157_ENST00000378878_TCGA-FS-A4F4-06A_LARP4B_chr10_909683_-_PAMR1_chr11_35515820_length(amino acids)=728AA_start in transcript=41_stop in transcript=2227 MTSDQDAKVVAEPQTQRVQEGKDSAHLMNGPISQTTSQTSSIPPLSQVPATKVSELNPNAEVWGAPVLHLEASSAADGVSAAWEEVAGHH ADRGPQGSDANGDGDQGHENAALPDPQESDPADMNALALGPSEYDSLPENSETEYTVINEACPGAEWNIMCRECCEYDQIECVCPGKREV VGYTIPCCRNEENECDSCLIHPGCTIFENCKSCRNGSWGGTLDDFYVKGFYCAECRAGWYGGDCMPCSSSPCFHDGTCVLDKAGSYKCAC LAGYTGQRCENLLEERNCSDPGGPVNGYQKITGGPGLINGRHAKIGTVVSFFCNNSYVLSGNEKRTCQQNGEWSGKQPICIKACREPKIS DLVRRRVLPMQVQSRETPLHQLYSAAFSKQKLQSAPTKKPALPFGDLPMGYQHLHTQLQYECISPFYRRLGSSRRTCLRTGKWSGRAPSC IPICGKIENITAPKTQGLRWPWQAAIYRRTSGVHDGSLHKGAWFLVCSGALVNERTVVVAAHCVTDLGKVTMIKTADLKVVLGKFYRDDD RDEKTIQSLQISAIILHPNYDPILLDADIAILKLLDKARISTRVQPICLAASRDLSTSFQESHITVAGWNVLADVRSPGFKNDTLRSGVV SVVDSLLCEEQHEDHGIPVSVTDNMFCASWEPTAPSDICTAETGGIAAVSFPGRASPEPRWHLMGLVSWSYDKTCSHRLSTAFTKVLPFK -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for LARP4B-PAMR1 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for LARP4B-PAMR1 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for LARP4B-PAMR1 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | LARP4B | C2931456 | Prostate cancer, familial | 1 | CTD_human |
| Hgene | LARP4B | C4722327 | PROSTATE CANCER, HEREDITARY, 1 | 1 | CTD_human |
| Tgene | PAMR1 | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
| Tgene | PAMR1 | C2239176 | Liver carcinoma | 1 | CTD_human |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies